Literature DB >> 20725913

Cognitive impairment in Parkinson's disease without dementia.

Javier Rodríguez-Ferreiro1, Fernando Cuetos, Elena Herrera, Manuel Menéndez, Renée Ribacoba.   

Abstract

Some degree of cognitive impairment appears frequently in Parkinson's disease (PD) patients, even at the onset of the disease. However, due to the heterogeneity of the patients and the lack of standardized assessment batteries, it remains unclear which capacities are primarily affected by this disease. Fifty PD patients were assessed with 15 tests including executive functions, attention, temporal and spatial orientation, memory, and language tasks. Their results were compared with those of 42 age- and education-matched healthy seniors. Semantic fluency, along with visual search appeared to be the most discriminant tasks, followed by temporal orientation and face naming, as well as action naming and immediate recall. PD patients studied showed an impairment of frontal- to posterior-dependent capacities. Executive functions, attention, and recall tasks appeared to be significantly impaired in the patients. Nevertheless, significantly poor scores in tasks like action and face naming, as well as semantic fluency, also reveal a mainly semantic deficit.

Entities:  

Mesh:

Year:  2010        PMID: 20725913     DOI: 10.1002/mds.23239

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  10 in total

1.  Understanding quantitative and qualitative figural fluency in patients with Parkinson's disease.

Authors:  Simone Goebel; Lubomir Atanassov; Günter Köhnken; H Maximilian Mehdorn; Bernd Leplow
Journal:  Neurol Sci       Date:  2012-11-18       Impact factor: 3.307

2.  The influence of dopamine on automatic and controlled semantic activation in Parkinson's disease.

Authors:  Wendy L Arnott; David A Copland; Helen J Chenery; Bruce E Murdoch; Peter A Silburn; Anthony J Angwin
Journal:  Parkinsons Dis       Date:  2011-11-02

3.  Affective theory of mind in Parkinson's disease: the effect of cognitive performance.

Authors:  Ana-Maria Romosan; Liana Dehelean; Radu-Stefan Romosan; Minodora Andor; Ana Cristina Bredicean; Mihaela Adriana Simu
Journal:  Neuropsychiatr Dis Treat       Date:  2019-08-30       Impact factor: 2.570

Review 4.  The Role of Mental Imagery in Parkinson's Disease Rehabilitation.

Authors:  Amit Abraham; Ryan P Duncan; Gammon M Earhart
Journal:  Brain Sci       Date:  2021-02-02

5.  Lexical-semantic search related to side of onset and putamen volume in Parkinson's disease.

Authors:  Daymond Wagner; Paul J Eslinger; Nicholas W Sterling; Guangwei Du; Eun-Young Lee; Martin Styner; Mechelle M Lewis; Xuemei Huang
Journal:  Brain Lang       Date:  2020-08-17       Impact factor: 2.381

6.  Verbal Fluency Performance in Patients with Non-demented Parkinson's Disease.

Authors:  Hooshang Dadgar; Ahmad Reza Khatoonabadi; Jalal Bakhtiyari
Journal:  Iran J Psychiatry       Date:  2013-03

7.  White matter hyperintensities in Parkinson's disease: do they explain the disparity between the postural instability gait difficulty and tremor dominant subtypes?

Authors:  Talia Herman; Keren Rosenberg-Katz; Yael Jacob; Eitan Auriel; Tanya Gurevich; Nir Giladi; Jeffrey M Hausdorff
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

8.  The emerging role of norepinephrine in cognitive dysfunctions of Parkinson's disease.

Authors:  Elena M Vazey; Gary Aston-Jones
Journal:  Front Behav Neurosci       Date:  2012-07-25       Impact factor: 3.558

9.  Higher Plasma LDL-Cholesterol is Associated with Preserved Executive and Fine Motor Functions in Parkinson's Disease.

Authors:  Nicholas W Sterling; Maya Lichtenstein; Eun-Young Lee; Mechelle M Lewis; Alicia Evans; Paul J Eslinger; Guangwei Du; Xiang Gao; Honglei Chen; Lan Kong; Xuemei Huang
Journal:  Aging Dis       Date:  2016-05-27       Impact factor: 6.745

10.  The Basis and Applications of the Action Fluency and Action Naming Tasks.

Authors:  Bárbara Costa Beber; Márcia L F Chaves
Journal:  Dement Neuropsychol       Date:  2014 Jan-Mar
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.